Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate

NCT01878006 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT01878006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01878006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2013
Completion date
April 27, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, pain, polymorphism-genetic